CancerTherapyAdvisor
@cancertheradvsr
CancerTherapyAdvisor.com is a resource offering oncology health care professionals practical information about the changing clinical landscape.
ID: 429091341
http://www.cancertherapyadvisor.com 05-12-2011 15:09:07
12,12K Tweet
7,7K Followers
526 Following
Sacituzumab govitecan demonstrated activity in patients with ES-SCLC in the phase 2 TROPiCS-03 trial. Presented at #WCLC24 by Dr Afshin Dowlati from Case Comp Cancer Ctr. #lcsm cancertherapyadvisor.com/reports/sacitu…